Loading…
Sens.ai assesses this as an incremental CPO testing partnership whose commercial significance will depend on whether the INS-2 platform reaches scaled deployment.
Limits of the evidence: The source is a single press report and gives no deployment volumes, timeline, or independently verified performance data.
What to watch
Assessment revised Oct 24, 2026
ficonTEC, Hermes Testing target CPO testing scale-up with INS-2 platform
DigiTimesOct 2, 2026First report
First assessment, from DigiTimes
No maturity ladder applies to this desk.
Sens.ai aggregates and assesses published reporting. The assessment above is machine generated; the original sources are authoritative.